- Supported exchanges /
- F /
- 65G.F
NEXTCELL PHARMA AB (65G F) stock market data APIs
€0.117
0(0%)
as of October 30, 2024
Price chart is built with Anychart
NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden. The company develops ProTrans, a drug candidate that consists of stem cells for the treatment of autoimmune disease, including type-1 diabetes. It also operates Cellaviva, a stem cell bank. The company was incorporated in 2014 and is based in Huddinge, Sweden.
NEXTCELL PHARMA AB Financial Data Overview
| 0.117 | |
| 0.117 | |
| - | |
| 0.117 | |
| 0.117 | |
| 0.0634-0.29 | |
| 13 004 K | |
| 73 091 K | |
| 11 278 K | |
| 0.735 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'65G',
Type:
'Common Stock',
Name:
'NEXTCELL PHARMA AB',
Exchange:
'F',
CurrencyCode:
'EUR',
CurrencyName:
'Euro',
CurrencySymbol:
'€',
CountryName:
'Germany',
CountryISO:
'DE',
OpenFigi:
NULL,
ISIN:
'SE0009723125',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'August',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
}
NEXTCELL PHARMA AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 11 278 K
- EBITDA -42 197 452
- Earnings Per Share -0.07
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get NEXTCELL PHARMA AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get NEXTCELL PHARMA AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
